These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Resistance in oral streptococci after repetition of a single-dose amoxycillin prophylactic regimen. Harrison GA, Rubin MP, Davies RM, Speller DC. J Antimicrob Chemother; 1985 Apr; 15(4):501-3. PubMed ID: 3847439 [Abstract] [Full Text] [Related]
4. Antibiotic-resistant oral streptococci in dental patients susceptible to infective endocarditis. Longman LP, Pearce PK, McGowan P, Hardy P, Martin MV. J Med Microbiol; 1991 Jan; 34(1):33-7. PubMed ID: 1990136 [Abstract] [Full Text] [Related]
5. Predominance of resistant oral streptococci in saliva and the effect of a single course of josamycin or erythromycin. Maskell JP, Sefton AM, Cannell H, Kerawala C, Seymour A, Sun ZM, Williams JD. J Antimicrob Chemother; 1990 Oct; 26(4):539-48. PubMed ID: 2254223 [Abstract] [Full Text] [Related]
6. Effect of repeated high dose prophylaxis with amoxycillin on the resident oral flora of adult volunteers. Woodman AJ, Vidic J, Newman HN, Marsh PD. J Med Microbiol; 1985 Feb; 19(1):15-23. PubMed ID: 3844036 [Abstract] [Full Text] [Related]
7. Erythromycin-resistant Streptococcus viridans in oral flora with prolonged erythromycin therapy. Bromberg K, Orson JM, Triedman R, Campognone P. Ann Intern Med; 1980 Dec; 93(6):931-2. PubMed ID: 6449896 [No Abstract] [Full Text] [Related]
8. Roxithromycin as a possible agent for prophylaxis of endocarditis: a study in normal volunteers. Smith GE, Fulford MR, Matthews RW, Speller DC. J Antimicrob Chemother; 1989 Mar; 23(3):417-25. PubMed ID: 2732123 [Abstract] [Full Text] [Related]
9. Macrolides and changes in the oral flora. Sefton AM. Int J Antimicrob Agents; 1999 Mar; 11 Suppl 1():S23-9; discussion S31-2. PubMed ID: 10204636 [Abstract] [Full Text] [Related]
10. Oral streptococci resistant to erythromycin after repetition of a regimen designed for dental prophylaxis. Herbert M, Moore E, Radford J, Kubiak E, Speller D. J Antimicrob Chemother; 1988 May; 21(5):677-9. PubMed ID: 3391867 [No Abstract] [Full Text] [Related]
11. In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species. Jalava J, Kataja J, Seppälä H, Huovinen P. Antimicrob Agents Chemother; 2001 Mar; 45(3):789-93. PubMed ID: 11181362 [Abstract] [Full Text] [Related]
12. In-vitro susceptibility of oral streptococci to pristinamycin. Maskell JP, Williams JD. J Antimicrob Chemother; 1987 May; 19(5):585-90. PubMed ID: 3112093 [Abstract] [Full Text] [Related]
18. Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms. Williams JD, Maskell JP, Shain H, Chrysos G, Sefton AM, Fraser HY, Hardie JM. J Antimicrob Chemother; 1992 Jul 21; 30(1):27-37. PubMed ID: 1331019 [Abstract] [Full Text] [Related]
19. The in-vitro activity of CP-62,993 against Haemophilus influenzae, Branhamella catarrhalis, staphylococci and streptococci. Dunkin KT, Jones S, Howard AJ. J Antimicrob Chemother; 1988 Apr 21; 21(4):405-11. PubMed ID: 2837451 [Abstract] [Full Text] [Related]
20. The development of penicillin-resistant oral streptococci after repeated penicillin prophylaxis. Fleming P, Feigal RJ, Kaplan EL, Liljemark WF, Little JW. Oral Surg Oral Med Oral Pathol; 1990 Oct 21; 70(4):440-4. PubMed ID: 2145541 [Abstract] [Full Text] [Related] Page: [Next] [New Search]